[1]
“ATTENUATED CYCLOSPORINE AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS”, Int. Res. J. Pharm., vol. 13, no. 5, pp. 39–43, May 2022, doi: 10.56802/w466yy68.